CN1266131C - 制备杂环茚类似物的方法 - Google Patents

制备杂环茚类似物的方法 Download PDF

Info

Publication number
CN1266131C
CN1266131C CNB028041208A CN02804120A CN1266131C CN 1266131 C CN1266131 C CN 1266131C CN B028041208 A CNB028041208 A CN B028041208A CN 02804120 A CN02804120 A CN 02804120A CN 1266131 C CN1266131 C CN 1266131C
Authority
CN
China
Prior art keywords
formula
compound
ring
benzenesulfonyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028041208A
Other languages
English (en)
Chinese (zh)
Other versions
CN1487922A (zh
Inventor
M·斯卡洛内
T·蔡贝加
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN1487922A publication Critical patent/CN1487922A/zh
Application granted granted Critical
Publication of CN1266131C publication Critical patent/CN1266131C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
CNB028041208A 2001-01-25 2002-01-22 制备杂环茚类似物的方法 Expired - Fee Related CN1266131C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01101584.9 2001-01-25
EP01101584 2001-01-25

Publications (2)

Publication Number Publication Date
CN1487922A CN1487922A (zh) 2004-04-07
CN1266131C true CN1266131C (zh) 2006-07-26

Family

ID=8176288

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028041208A Expired - Fee Related CN1266131C (zh) 2001-01-25 2002-01-22 制备杂环茚类似物的方法

Country Status (9)

Country Link
US (2) US6777559B2 (https=)
EP (1) EP1355880A2 (https=)
JP (1) JP4056883B2 (https=)
KR (1) KR100559019B1 (https=)
CN (1) CN1266131C (https=)
CA (1) CA2434408C (https=)
JO (1) JO2433B1 (https=)
MX (1) MXPA03006606A (https=)
WO (1) WO2002059089A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004501191A (ja) * 2000-06-28 2004-01-15 テバ　ファーマシューティカル　インダストリーズ　リミティド カルベジロール
MXPA04006909A (es) 2002-01-15 2005-04-19 Teva Pharma Solidos cristalinos de carvedilol y procesos para su preparacion.
US20070191456A1 (en) * 2004-04-22 2007-08-16 Tarur Venkatasubramanian R Novel process for the preparation of 1-(9h-carbazol-4-yloxy)-3-[[2-(-methoxyphenoxy)-ethyl] amino]-propan-2-ol
GB0411273D0 (en) * 2004-05-20 2004-06-23 Cipla Ltd Process and product
US20070043099A1 (en) * 2005-06-09 2007-02-22 Igor Lifshitz Crystalline forms of carvedilol and processes for their preparation
WO2008002683A2 (en) * 2006-06-28 2008-01-03 Teva Pharmaceutical Industries Ltd. Polymorphous forms of carvedilol phosphate
WO2008038301A1 (en) * 2006-09-26 2008-04-03 Morepen Laboratories Limited A process for the preparation of carvedilol
US20080207726A1 (en) * 2007-02-26 2008-08-28 Santiago Ini Process for the purification of carvedilol or its salts thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2258431T3 (es) 1999-08-02 2006-09-01 F. Hoffmann-La Roche Ag Proceso para la preparacion de derivados de benzotiofeno.

Also Published As

Publication number Publication date
JP2004519465A (ja) 2004-07-02
EP1355880A2 (en) 2003-10-29
CA2434408A1 (en) 2002-08-01
WO2002059089A3 (en) 2002-10-31
JO2433B1 (en) 2008-04-17
MXPA03006606A (es) 2003-09-22
US20040127723A1 (en) 2004-07-01
WO2002059089A2 (en) 2002-08-01
KR100559019B1 (ko) 2006-03-10
KR20030077007A (ko) 2003-09-29
CN1487922A (zh) 2004-04-07
US7169935B2 (en) 2007-01-30
US20020099223A1 (en) 2002-07-25
JP4056883B2 (ja) 2008-03-05
CA2434408C (en) 2009-10-20
US6777559B2 (en) 2004-08-17

Similar Documents

Publication Publication Date Title
CN87107175A (zh) 作为抗溃疡剂的新苯并咪唑衍生物
CN1166835A (zh) 光学活性金属茂基膦的制备方法
CN1030075C (zh) 新的3-环烷基丙酰胺，它们的互变异构体及其盐类的制备方法
CN1217930C (zh) 吲哚衍生物的制备方法和该方法的中间体
CN1183118C (zh) 4-烷氧基-环己烷-1-氨基-羧酸酯及其生产方法
CN1119321C (zh) 手性β－氨基酸的不对称合成
CN1377348A (zh) 4,5－二芳基噁唑化合物
CN1266131C (zh) 制备杂环茚类似物的方法
CN1276914C (zh) 新型环己基砜化合物
CN1729173A (zh) N－(吲哚乙基)环胺化合物
CN1033391C (zh) 新的-β-咔啉衍生物的制备方法
CN1860115A (zh) 制备手性丙酸衍生物的方法
CN1617848A (zh) 结晶文拉法辛碱、新的盐酸文拉法辛多晶型物及它们的制备方法
CN1330065A (zh) 用于制备对映纯的吲哚羧酸类及其活性衍生物的中间体
CN1377337A (zh) 苯乙酸衍生物的制备方法
CN1400974A (zh) 氨基酸化合物及其作为nep、ace和ece抑制剂的用途
CN1349501A (zh) 三环氨基衍生物的新的制备方法
CN1461301A (zh) 苯并[b]噻吩衍生物及其制备方法
CN1053604A (zh) 氨基甲酰基衍生物
CN1886371A (zh) 氟伐他汀钠多晶型物的制备方法
CN1275940C (zh) 苯基烷氧基－苯基衍生物
CN1195739C (zh) 2－氨磺酰苯甲酸衍生物
CN87107427A (zh) 取代的氨甲基-5，6，7，8-四氢萘氧代乙酸，新的中间体产物，它们的制备过程及其作为药物的应用
CN101056853A (zh) 异吲哚衍生物的制备方法
CN1185214C (zh) 新的茚并吲哚酮化合物,其制备方法和含有这种化合物的药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060726

Termination date: 20120122